Joyce
Analyst
JPMorgan
Equibles does not estimate personal net worth.
About Joyce
Joyce is recorded as Analyst at JPMorgan. Joyce has spoken on 1 earnings call across 1 company, most recently for CytomX Therapeutics, Inc. on May 7, 2026. The companies whose calls Joyce spoke on are classified in the Healthcare sector.
Joyce on recent calls
“I think previously you had said you were targeting mid-year FDA interactions to start discussing the pivotal trial design. To what extent is reaching alignment on the trial design ultimately gated on seeing your dose optimization update later this year?”
Affiliation history
-
JPMorgan
Analyst
Transcript header (unverified)
Current